Michael Goettler, Viatris CEO
October 12, 2022 02:22 PM EDT
Deals
Pharma

Vi­a­tris weighs sale of Eu­ro­pean con­sumer health busi­ness — re­port

Nicole DeFeudis

Editor

Fol­low­ing in the foot­steps of GSK and J&J, Vi­a­tris is re­port­ed­ly weigh­ing plans to ditch its con­sumer health as­sets.

Vi­a­tris is con­sid­er­ing a deal for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times